Iranian journal of pharmaceutical research : IJPR · 2025
Capparis spinosa Attenuates Hepatic Inflammation and Fibrosis by Suppressing Inflammatory Cytokines in a Wistar Rat Model of Nonalcoholic Steatohepatitis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Akbari Rasoul, Behdarvand Tahereh, Yaghooti Hamid, Jalali Mohammad Taha, Mohammadtaghvaei Narges
Аннотация
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic hepatic condition that can progress to non-alcoholic steatohepatitis (NASH) through inflammatory processes.
OBJECTIVES: This research aimed to examine the impact of an aqueous extract of Capparis spinosa fruit and the lipid-lowering agent fenofibrate (FENO) on hepatic inflammation and steatosis in rats subjected to a high-fat emulsion.
METHODS: Male Wistar rats were given a high-fat diet (HFD) to develop NASH. The high-fat treated rats were categorized into three groups and administered either C. spinosa, FENO, or a vehicle control. Histopathological analyses, Liver Index computation, and measurements of body and liver weights were conducted. Serum levels of liver enzymes, adiponectin, and leptin were also assessed. Additionally, the expression of hepatic genes for monocyte chemoattractant protein 1 (MCP-1), transforming growth factor-beta (TGF-β), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α) was evaluated.
RESULTS: The administration of C. spinosa extract to the NASH model rodents significantly increased their adiponectin levels while substantially decreasing their levels of leptin, alanine aminotransferase (ALT), and aspartate transaminase (AST). Hepatic steatosis, liver inflammation, and collagen deposition were significantly reduced by C. spinosa treatment. Furthermore, the hepatic mRNA expression of the proinflammatory cytokines TNF-α, IL-6, and MCP-1, as well as the hepatic fibrogenic marker TGF-β1, was significantly reduced by C. spinosa treatment. The FENO exhibited a comparable pattern of response.
CONCLUSIONS: Our findings suggest that C. spinosa has a positive anti-inflammatory effect and may protect the liver against hepatic fibrosis, inflammation, and steatosis. These findings demonstrate the promising therapeutic potential of C. spinosa in the management of NASH.
OBJECTIVES: This research aimed to examine the impact of an aqueous extract of Capparis spinosa fruit and the lipid-lowering agent fenofibrate (FENO) on hepatic inflammation and steatosis in rats subjected to a high-fat emulsion.
METHODS: Male Wistar rats were given a high-fat diet (HFD) to develop NASH. The high-fat treated rats were categorized into three groups and administered either C. spinosa, FENO, or a vehicle control. Histopathological analyses, Liver Index computation, and measurements of body and liver weights were conducted. Serum levels of liver enzymes, adiponectin, and leptin were also assessed. Additionally, the expression of hepatic genes for monocyte chemoattractant protein 1 (MCP-1), transforming growth factor-beta (TGF-β), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α) was evaluated.
RESULTS: The administration of C. spinosa extract to the NASH model rodents significantly increased their adiponectin levels while substantially decreasing their levels of leptin, alanine aminotransferase (ALT), and aspartate transaminase (AST). Hepatic steatosis, liver inflammation, and collagen deposition were significantly reduced by C. spinosa treatment. Furthermore, the hepatic mRNA expression of the proinflammatory cytokines TNF-α, IL-6, and MCP-1, as well as the hepatic fibrogenic marker TGF-β1, was significantly reduced by C. spinosa treatment. The FENO exhibited a comparable pattern of response.
CONCLUSIONS: Our findings suggest that C. spinosa has a positive anti-inflammatory effect and may protect the liver against hepatic fibrosis, inflammation, and steatosis. These findings demonstrate the promising therapeutic potential of C. spinosa in the management of NASH.